Oliver Klein

Loading... 2 0 20 0 false
Credit Name
Oliver Klein
Full Name
Klein, Oliver
 
Department
 
Loading... 3 0 20 0 false

Publications

Results 1-20 of 33 (Search time: 0.01 seconds).

Publication YearTitleAuthor(s)
11-Jan-2024Assessing Response for Nivolumab Plus Ipilimumab in Squamous Cell Carcinoma of the Head and Neck.Klein, Oliver 
220-Nov-2023The features and management of acquired resistance to PD1-based therapy in metastatic melanoma.Hepner, Adriana; Versluis, Judith M; Wallace, Roslyn; Allayous, Clara; Brown, Lauren Julia; Trojaniello, Claudia; Gerard, Camille Lea; Jansen, Yanina Jl; Bhave, Prachi; Neyns, Bart; Haydon, Andrew; Michielin, Olivier; Mangana, Joanna; Klein, Oliver ; Shoushtari, Alexander N; Warner, Allison Betof; Ascierto, Paolo Antonio; McQuade, Jennifer Leigh; Carlino, Matteo S; Zimmer, Lisa; Lebbe, Celeste; Johnson, Douglas B; Sandhu, Shahneen; Atkinson, Victoria; Blank, Christian U; Lo, Serigne N; Long, Georgina V; Menzies, Alexander M
322-Sep-2023Durable response to combination immunotherapy using nivolumab and ipilimumab in metastatic succinate dehydrogenase (SDH)-deficient gastrointestinal stroma tumour.Klein, Oliver ; Palmer, Jodie ; Behren, Andreas; Cebon, Jonathan S ; Kee, Damien 
44-May-2023Targeting homologous recombination deficiency in uterine leiomyosarcomaDall, Genevieve; Vandenberg, Cassandra J; Nesic, Ksenija; Ratnayake, Gayanie; Zhu, Wenying; Vissers, Joseph H A; Bedő, Justin; Penington, Jocelyn; Wakefield, Matthew J; Kee, Damien ; Carmagnac, Amandine; Lim, Ratana; Shield-Artin, Kristy; Milesi, Briony; Lobley, Amanda; Kyran, Elizabeth L; O'Grady, Emily; Tram, Joshua; Zhou, Warren; Nugawela, Devindee; Stewart, Kym Pham; Caldwell, Reece; Papadopoulos, Lia; Ng, Ashley P; Dobrovic, Alexander ; Fox, Stephen B; McNally, Orla; Power, Jeremy D; Meniawy, Tarek; Tan, Teng Han; Collins, Ian M; Klein, Oliver ; Barnett, Stephen A ; Olesen, Inger; Hamilton, Anne; Hofmann, Oliver; Grimmond, Sean; Papenfuss, Anthony T; Scott, Clare L; Barker, Holly E
51-Apr-2023Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?Klein, Oliver ; Kee, Damien ; Nagrial, Adnan; Markman, Ben; Underhill, Craig; Michael, Michael; Behren, Andreas; Palmer, Jodie ; Tebbutt, Niall C ; Carlino, Matteo S; Cebon, Jonathan S 
6Jul-2022Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma.Bhave, Prachi; Ahmed, Tasnia; Lo, Serigne N; Shoushtari, Alexander; Zaremba, Anne; Versluis, Judith M; Mangana, Joanna; Weichenthal, Michael; Si, Lu; Lesimple, Thierry; Robert, Caroline; Trojanello, Claudia; Wicky, Alexandre; Heywood, Richard; Tran, Lena; Batty, Kathleen; Dimitriou, Florentia; Stansfeld, Anna; Allayous, Clara; Schwarze, Julia K; Mooradian, Meghan J; Klein, Oliver ; Mehmi, Inderjit; Roberts-Thomson, Rachel; Maurichi, Andrea; Yeoh, Hui-Ling; Khattak, Adnan; Zimmer, Lisa; Blank, Christian U; Ramelyte, Egle; Kähler, Katharina C; Roy, Severine; Ascierto, Paolo A; Michielin, Olivier; Lorigan, Paul C; Johnson, Douglas B; Plummer, Ruth; Lebbe, Celeste; Neyns, Bart; Sullivan, Ryan; Hamid, Omid; Santinami, Mario; McArthur, Grant A; Haydon, Andrew M; Long, Georgina V; Menzies, Alexander M; Carlino, Matteo S
76-Jun-2022Talimogene laherparepvec resulting in near-complete response in a patient with treatment-refractory Merkel cell carcinoma.Cilento, Michael A; Klein, Oliver ; Egan, Elizabeth; Roberts-Thomson, Rachel
88-Apr-2022'Know thyself'- host factors influencing cancer response to immune checkpoint inhibitors.Gunjur, Ashray ; Manrique-Rincón, Andrea J; Klein, Oliver ; Behren, Andreas; Lawley, Trevor D; Welsh, Sarah J; Adams, David J
92022Single-agent anti-PD-1 or combined with ipilimumab in patients with mucosal melanoma: an international, retrospective, cohort study.Dimitriou, F; Namikawa, K; Reijers, I L M; Buchbinder, E I; Soon, J A; Zaremba, A; Teterycz, P; Mooradian, M J; Armstrong, E; Nakamura, Y; Vitale, M G; Tran, L E; Bai, X; Allayous, C; Provent-Roy, S; Indini, A; Bhave, P; Farid, M; Kähler, K C; Mehmi, I; Atkinson, V; Klein, Oliver ; Stonesifer, C J; Zaman, F; Haydon, A; Carvajal, R D; Hamid, O; Dummer, R; Hauschild, A; Carlino, M S; Mandala, M; Robert, C; Lebbe, C; Guo, J; Johnson, D B; Ascierto, P A; Shoushtari, A N; Sullivan, R J; Cybulska-Stopa, B; Rutkowski, P; Zimmer, L; Sandhu, S ; Blank, C U; Lo, S N; Menzies, A M; Long, G V
102022Enhancing therapeutic anti-cancer responses by combining immune checkpoint and tyrosine kinase inhibition.Daly, Roger J; Scott, Andrew M ; Klein, Oliver ; Ernst, Matthias 
11Nov-2021Combination immunotherapy with nivolumab and ipilimumab in patients with rare gynecological malignancies: results of the CA209-538 clinical trial.Klein, Oliver ; Kee, Damien ; Gao, Bo; Markman, Ben; da Gama Duarte, Jessica; Quigley, Luke; Jackett, Louise A ; Linklater, Richelle; Strickland, Andrew; Scott, Clare; Mileshkin, Linda; Palmer, Jodie ; Carlino, Matteo; Behren, Andreas; Cebon, Jonathan S 
12Oct-2021A rare case of solitary gallbladder metastasis from an early cutaneous melanoma.Doole, Emily Louise; Gan, Philip; Klein, Oliver 
13Aug-2021Ipilimumab versus ipilimumab plus anti-PD-1 for metastatic melanoma - Authors' reply.da Silva, Ines Pires; Ahmed, Tasnia; Reijers, Irene L M; Warner, Allison Betof; Patrinely, James Randall; Serra-Bellver, Patricio; Allayous, Clara; Mangana, Joanna; Zimmer, Lisa; Trojaniello, Claudia; Klein, Oliver ; Gerard, Camille L; Michielin, Olivier; Haydon, Andrew; Ascierto, Paolo A; Carlino, Matteo S; Lebbe, Celeste; Lorigan, Paul; Johnson, Douglas B; Sandhu, Shahneen; Lo, Serigne N; Menzies, Alexander M; Long, Georgina V
1428-Jun-2021Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti-PD-1 therapy.Hepner, Adriana; Atkinson, Victoria G; Larkin, James; Burrell, Rebecca A; Carlino, Matteo S; Johnson, Douglas B; Zimmer, Lisa; Tsai, Katy K; Klein, Oliver ; Lo, Serigne N; Haydon, Andrew; Bhave, Prachi; Lyle, Megan; Pallan, Lalit; Pires da Silva, Ines; Gerard, Camille; Michielin, Olivier; Long, Georgina V; Menzies, Alexander M
159-Jun-2021PDCD1 Polymorphisms May Predict Response to Anti-PD-1 Blockade in Patients With Metastatic Melanoma.Parakh, Sagun ; Musafer, Ashan; Paessler, Sabrina; Witkowski, Tom ; Suen, Connie S N Li Wai; Tutuka, Candani S A; Carlino, Matteo S; Menzies, Alexander M; Scolyer, Richard A; Cebon, Jonathan S ; Dobrovic, Alexander ; Long, Georgina V; Klein, Oliver ; Behren, Andreas
16Jun-2021Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study.Pires da Silva, Ines; Ahmed, Tasnia; Reijers, Irene L M; Weppler, Alison M; Betof Warner, Allison; Patrinely, James Randall; Serra-Bellver, Patricio; Allayous, Clara; Mangana, Joanna; Nguyen, Khang; Zimmer, Lisa; Trojaniello, Claudia; Stout, Dan; Lyle, Megan; Klein, Oliver ; Gerard, Camille L; Michielin, Olivier; Haydon, Andrew; Ascierto, Paolo A; Carlino, Matteo S; Lebbe, Celeste; Lorigan, Paul; Johnson, Douglas B; Sandhu, Shahneen; Lo, Serigne N; Blank, Christian U; Menzies, Alexander M; Long, Georgina V
17Jun-2021Salvage treatment using anti-PD-1/CTLA-4 immunotherapy after failure of neoadjuvant chemotherapy in microsatellite instable gastroesophageal carcinoma.Klein, Oliver ; Brown, Wendy A; Saxon, Sarah; Haydon, Andrew
1829-Apr-2021Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy.Klein, Oliver ; Kee, Damien ; Markman, Ben; Carlino, Matteo S; Underhill, Craig; Palmer, Jodie ; Power, Daniel; Cebon, Jonathan S ; Behren, Andreas
1912-Apr-2021Combination immunotherapy with ipilimumab and nivolumab in patients with advanced adrenocortical carcinoma: a subgroup analysis of CA209-538.Klein, Oliver ; Senko, Clare ; Carlino, Matteo S; Markman, Ben; Jackett, Louise A ; Gao, Bo; Lum, Caroline; Kee, Damien ; Behren, Andreas; Palmer, Jodie ; Cebon, Jonathan S 
20Dec-2020Complete response of metastatic pleomorphic dermal sarcoma to anti-PD-1 therapy.Klein, Oliver ; McTigue, C; Wong, Z W; Syme, D B; Hunter-Smith, D J